Cardiac Science’s Loss
- Share via
Cardiac Science Inc., Irvine developer of medical products. reported a net loss of $711,506, or 14 cents a share, for the first quarter, compared with a net loss of $168,475, or 5 cents a share, for the like period last year. Revenue totaled $446,712. No revenue was reported for the 1997 first quarter.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
